XML 33 R13.htm IDEA: XBRL DOCUMENT v3.23.1
Employees
12 Months Ended
Dec. 31, 2022
Employees

8. Employees

  

  

Year ended

December 31,

  

Year ended

December 31,

  

Year ended

December 31,

 
  

2022

Number

  

2021

Number

  

2020

Number

 
Number of employees            
Average monthly number or persons (including directors) employed by the Group:               
Research and development   70    61    66 
Management, administration and operations   9    8    13 
Number of employees   79    69    79 

 

 

TC BIOPHARM (HOLDINGS) PLC

 

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

 

8. Employees (continued)

 

Management includes employees who are involved in both research and development and administrative operations.

 

  

Year ended

December 31,

  

Year ended

December 31,

  

Year ended

December 31,

 
   2022   2021   2020 
   £   £   £ 
Staff costs – included in research and development               
Wages and salaries   3,512,525    2,989,066    3,443,726 
Social security costs   432,388    313,138    386,063 
Pension costs – defined contribution   156,360    94,938    130,339 
Share based payments   403,803    -    316,259 
Total staff costs   4,505,076    3,397,142    4,276,387 
Staff costs – included in administrative expenses               
Wages and salaries   1,586,591    877,752    703,366 
Social security costs   249,091    56,646    99,040 
Pension costs – defined contribution   59,801    42,034    24,548 
Share based payments   719,447    -    256,803 
Total staff costs   2,614,930    976,432    1,083,757 
Staff costs – combined               
Wages and salaries   5,099,116    3,866,818    4,147,091 
Social security costs   681,479    369,784    485,102 
Pension costs – defined contribution   216,161    136,972    154,887 
Share based payments   1,123,250    -    573,062 
Total staff costs   7,120,006    4,373,574    5,360,142 

 

Directors’ remuneration 

Year ended

December 31,

   Year ended December 31,  

Year ended

December 31,

 
   2022   2021   2020 
   £   £   £ 
Directors’ remuneration in respect of qualifying services   1,203,537    1,046,324    967,651 
Directors’ employer’s pension contributions   72,176    15,001    14,376 
Directors remuneration   1,275,713    1,061,325    982,027 

 

The total remuneration of the highest paid or receivable by the highest paid director in the year ended December 31, 2022 was £443,817 (2021: £332,468 and 2020: £365,194). The Group pension contributions in respect of the highest paid director totaled £Nil for the year to December 31, 2022 (2021: £Nil and 2020: £Nil). The highest paid director did not exercise any share options in the period. No other directors exercised share options in the period.

 

 

TC BIOPHARM (HOLDINGS) PLC

 

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)